Open Access<p><em>Clostridium histolyticum</em> (AA4500) for the Treatment of Adhesive Capsulitis of the Shoulder: A Randomised Double-Blind, Placebo-Controlled Study for the Safety and Efficacy of Collagenase – Single Site Report</p>
Author(s) -
Jane Fitzpatrick,
Christen Richardson,
Ianiv Klaber,
Martin Richardson
Publication year - 2020
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s259228
Subject(s) - medicine , capsulitis , placebo , randomized controlled trial , adverse effect , shoulder joint , surgery , range of motion , clinical trial , physical therapy , alternative medicine , pathology
Adhesive capsulitis of the shoulder results in pain and restricted movement of the glenohumeral joint. Hypothesis: There would be a difference in active range of movement in the affected shoulder of patients with adhesive capsulitis after receiving a series of injections of collagenase Clostridium histolyticum (CCH) compared to placebo.